Soleus Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Soleus Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,084,050	Closed	-$12.7M	–	93
2021 Q3	$12.7M	Buy	+2,084,050	New	+$13M	1.98%	16
2021 Q2	–	Sell	-522,500	Closed	-$4.68M	–	87
2021 Q1	$4.68M	Buy	+522,500	New	+$5.99M	0.84%	22
2020 Q1	–	Sell	-34,900	Closed	-$722K	–	65
2019 Q4	$722K	Buy	+34,900	New	+$589K	0.7%	33

Soleus Capital Management's FLXN Position: Q4 2021 in Review

Soleus Capital Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 2,084,050 shares — an estimated $12.7M sold.

Soleus Capital Management first reported a position in FLXN in Q4 2019 and held it in 3 quarters. The position peaked at $12.7M in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Soleus Capital Management reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Soleus Capital Management sold 2,084,050 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $12.7M.
Soleus Capital Management first reported a position in Flexion Therapeutics, Inc. in Q4 2019 and held it in 3 quarters.
Soleus Capital Management's Flexion Therapeutics, Inc. position peaked at $12.7M in Q3 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Soleus Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.